Announcements Trials
Browse Landscape

Phase

Phase 2 223Phase 1/2 109Phase 1 102Phase 3 91Phase 2/3 17Phase EARLY_PHASE1 6Phase NA 4Phase 4 3

Status

Unknown 7Recruiting 4Completed 4Terminated 2Not yet recruiting 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Dermatologic 2Thoracic 1

Conditions

Skin Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Mouth Neoplasms 1Melanoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 104Standard of Care 79Exercise 67Radiotherapy 53Radiosurgery 48Specimen Handling 45Magnetic Resonance Spectroscopy 45Surveys and Questionnaires 44Interviews as Topic 44Practice Guidelines as Topic 43Educational Status 43Methods 41Drug Therapy 35Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Control Groups 25Biopsy 24Patient Navigation 18venetoclax 17Cisplatin 17Therapeutics 16Resistance Training 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 13Cognitive Behavioral Therapy 13Acupuncture Therapy 13Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Recruiting × pembrolizumab × Clear all
NCT07343596 2026-04-22

Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery

University of Wisconsin, Madison

Phase NA Recruiting
20 enrolled
Head & Neck

Mouth Neoplasms

NCT05047094 2026-04-06

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Alpha Tau Medical LTD.

Phase NA Recruiting
48 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT07422779 2026-02-20

MAK

Institute of Oncology Ljubljana

Phase NA Recruiting
100 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT03769129 2024-06-25

Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC

Second Affiliated Hospital of Guangzhou Medical University

Phase NA Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡